Abstract
Inflammation has been identified as a possible contributory factor to disruption of the normal bone remodeling process, a process essential to healthy bone mineral density. Several large population-based clinical studies have specifically shown that levels of C-reactive protein, an immune recognition protein that is a sensitive marker of inflammation, are inversely and independently associated with total bone mineral density. The evidence suggests that control of C-reactive protein levels may contribute to bone health by protecting against inflammation’s disruption of the equilibrium between bone resorption and bone deposition. Calcium fructoborate, a patented complex of calcium, fructose, and boron found naturally in fresh and dried fruits, vegetables and herbs, and wine, is a sugar-borate ester. A growing body of peer-reviewed, published clinical research indicates that the calcium fructoborate significantly reduces serum levels of the C-reactive protein in humans, suggesting that this unique plant–mineral complex may contribute to bone health by controlling the inflammation associated with loss of bone mineral density.
Similar content being viewed by others
Abbreviations
- AA:
-
Arachidonic acid
- ALP:
-
Alkaline phosphatase
- BMD:
-
Bone mineral density
- CF:
-
Calcium fructoborate
- COX-2:
-
Cyclooxygenase-2
- CRP:
-
C-reactive protein
- ESR:
-
Erythrocyte sedimentation rate
- FBR:
-
Fibrinogen
- hs-CRP:
-
High-sensitivity C-reactive protein
- IL:
-
Interleukin
- LPS:
-
Lipopolysaccharide
- SBE:
-
Sugar-borate ester
- TNF-alfa:
-
Tumor necrosis factor-alfa
References
Dembitsky VM, Smoum R, Al-Quntar AAA, Ali HA, Pergament I, Srebnik M (2009) Natural occurrence of boron-containing compounds in plants, algae and microorganisms. Plant Sci 163:931–942
Ishii T, Matsunaga T (1996) Isolation and characterization of a boron-rhamnogalacturonan-II complex from cell walls of sugar beet pulp. Carbohydr Res 284:1–9
Matsunaga I, Ishi T, Watanbe H (1996) Speciation of water-soluble boron compounds in radish roots by size exclusion HPLC/ICP-MS. Anal Sci 12:673–675
Matsunaga T, Nagata N (1995) In vivo 11B NMR observation of plant tissue. Anal Sci 11:889–892
Hunt CD (2012) Dietary boron: progress in establishing essential roles in human physiology. J Trace Elem Exp Biol 26:157–160
Goldbach HE, Huang L, Wimmer MA (2007) Boron functions in plants and animals: recent advances in boron research and open questions. In: Xu F, Goldbach HE, Brown PH et al (eds) Advances in plant and animal boron nutrition. Springer, Dordrecht, pp 3–25
Nielsen FH (2008) Is boron nutritionally relevant? Nutr Rev 66(4):183–191
Nielsen F, Meacham S (2011) Growing evidence for human health benefits of boron. J Evid Based Complement Alternat Med 16:3169–3180
Hunt CD, Idso JP (1999) Dietary boron as a physiological regulator of the normal inflammatory response: a review and current research progress. J Trace Elem Exp Biol 12:221–233
Hunt CD (2003) Dietary boron: an overview of the evidence for its role in immune function. J Trace Elem Exp Biol 16:291–306
Hunt CD, Herbel JL, Idso JP (1994) Dietary boron modifies the effects of vitamin D3 nutriture on indices of energy substrate utilization and mineral metabolism in the chick. J Bone Miner Res 9:171–181
Scorei RI, Rotaru P (2011) Calcium fructoborate—potential anti-inflammatory agent. Biol Trace Elem Res 143(3):1223–1238
Wagner CC, Ferraresi Curotto V, Pis Diez R, Baran EJ (2008) Experimental and theoretical studies of calcium fructoborate. Biol Trace Elem Res 122:64–72
Miljkovic D, Scorei IR, Cimpoiasu VM, Scorei ID (2009) Calcium fructoborate: plant based dietary boron for human nutrition. J Diet Suppl 6:211–226
Rotaru P, Scorei R, Harabor A, Dumitru MD (2010) Thermal analysis of a calcium fructoborate sample. Thermochim Acta 506:8–13
Scorei R, Ciubar R, Iancu C, Mitran V, Cimpean A, Iordachescu D (2007) In vitro effects of calcium fructoborate on fMLP-stimulated human neutrophil granulocytes. Biol Trace Elem Res 118:27–37
Scorei RI, Ciofrangeanu C, Ion R et al (2010) In vitro effects of calcium fructoborate upon production of inflammatory mediators by LPS-stimulated RAW 264.7 macrophages. Biol Trace Elem Res 135:334–344
Scorei R, Mitrut P, Petrisor I, Scorei ID (2011) A double-blind, placebo-controlled pilot study to evaluate the effect of calcium fructoborate on systemic inflammation and dyslipidemia markers for middle-aged people with primary osteoarthritis. Biol Trace Elem Res 144(1–3):253–263
Reyes-Izquierdo T, Nemzer B, Gonzalez AE, Zhou Q, Argumedo R, Shu C, Pietrzkowski ZB (2012) Short-term intake of calcium fructoborate improves WOMAC and McGill scores and beneficially modulates biomarkers associated with knee osteoarthritis: a pilot clinical double-blinded placebo-controlled study. J Biomed Sci 4(2):111–122
Militaru C, Donoiu I, Craciun A, Scorei ID, Bulearca AM, Scorei RI (2013) Oral resveratrol and calcium fructoborate supplementation in subjects with stable angina pectoris: effects on lipid profiles, inflammation markers, and quality of life. Nutrition 29(1):178–183
Du Clos TW (2000) Function of C-reactive protein. Ann Med 32(4):274–278
Dehghan A, Kardys I, de Maat MP, Uitterlinden AG, Sijbrands EJ, Bootsma AH, Stijnen T, Hofman A, Schram MT, Witteman JC (2007) Genetic variation, C-reactive protein levels, and incidence of diabetes. Diabetes 56(3):872–878
Ridker PM (2003) Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 107:363–369
Devaraj S, Singh U, Jialal I (2009) Human C-reactive protein and the metabolic syndrome. Curr Opin Lipidol 20(3):182–189
Smith JW, Martins TB, Gopez E, Johnson T, Hill HR, Rosenberg TD (2012) Significance of C-reactive protein in osteoarthritis and total knee arthroplasty outcomes. Ther Adv Musculoskelet Dis 4(5):315–325
Devlin J, Gough A, Huissoon A, Perkins P, Holder R, Reece R, Arthur V, Emery P (1997) The acute phase and function in early rheumatoid arthritis. C-reactive protein levels correlate with functional outcome. J Rheumatol 24(1):9–13
Koh J-M, Khang Y-H, Jung C-H, Bae S, Kim DJ, Chung Y-E Kim GS (2005) Higher circulating hsCRP levels are associated with lower bone mineral density in healthy pre- and postmenopausal women: evidence for a link between systemic inflammation and osteoporosis. Osteoporos Int 16:1263–1271
De Pablo P, Cooper MS, Buckley CD (2012) Association between bone mineral density and C-reactive protein in a large population-based sample. Arthritis Rheum 64(8):2624–2631
Tanaka Y, Nakayamada S, Okada Y (2005) Osteoblasts and osteoclasts in bone remodeling and inflammation. Curr Drug Targets Inflamm Allergy 4(3):325–328
Thmson BM, Mundy GR, Chambers TJ (1987) Tumor necrosis factors alpha and beta induce osteoblastic cells to stimulate osteoclastic bone resorption. J Immun 138:775–779
Hardy R, Cooper MS (2009) Bone loss in inflammatory disorders. J Endocrinol 201:309–320
Stobaugh DJ, Deepak P, Ehrenpreis ED (2013) Increased risk of osteoporosis-related fractures in patients with irritable bowel syndrome. Osteoporos Int 24(4):1169–1175
Weitzmann MN, Pacifici R (2006) Estrogen deficiency and bone loss: an inflammatory tale. J Clin Invest 116(5):1186–1194
Manda D, Popa O, Vladoiu S, Dumitrache C (2009) Calcium fructoborate effect on osteoblast mineralization in vitro. Bone 44(2):S298–S299
Dinca L, Scorei R (2013) Boron in human nutrition and its regulations use. J Nutr Ther 2(1):22–28
Goldring SR (2003) Bone loss in chronic inflammatory conditions. J Musculoskel Neuron Interact 3(4):287–289
Goldring SR, Gravallese EM (2000) Mechanisms of bone loss in inflammatory arthritis: diagnosis and therapeutic implications. Arthritis Res 2:33–37
Gough AK, Lilley J, Eyre S, Holder RL, Emery P (1994) Generalised bone loss in patients with early rheumatoid arthritis. Lancet 344:23–27
Spector TD, Hall GM, McCloskey EV, Kanis JA (1993) Risk of vertebral fracture in women with rheumatoid arthritis. Br Med J 306:558
Schoon EJ, Blok BM, Geerling BJ, Russel MG, Stockbrugger RW, Brummer RJ (2000) Bone mineral density in patients with recently diagnosed inflammatory bowel disease. Gastroenterology 119:1203–1208
Bultink IE, Lems WF, Kostense PJ, Dijkmans BA, Voskuyl AE (2005) Prevalence of and risk factors for low bone mineral density and vertebral fractures in patients with systemic lupus erythematosus. Arthritis Rheum 52:2044–2050
Mantovani A, Garlanda C, Doni A, Bottazzi B (2008) Pentraxins in innate immunity: from C-reactive protein to the long pentraxin PTX3. J Clin Immunol 28:1–13
Koukkunen H, Penttilä K, Kemppainen A, Halinen M, Penttila I, Rantanen T, Pyörälä K (2001) C-reactive protein, fibrinogen, interleukin-6 and tumour necrosis factor-alpha in the prognostic classification of unstable angina pectoris. Ann Med 33(1):37–47
Thomson BM, Mundy GR, Chambers TJ (1987) Tumor necrosis factors alpha and beta induce osteoblastic cells to stimulate osteoclastic bone resorption. J Immunol 138:775–779
Ginaldi L, Di Benedetto MC, De Martinis M (2005) Osteoporosis, inflammation and ageing. Immun Ageing 2:14. doi:10.1186/1742-4933-2-14
Rifai N, Ridker PM (2001) High-sensitivity C-reactive protein: a novel and promising marker of coronary heart disease. Clin Chem 47(3):403–411
Attur M, Krasnokutsky-Samuels S, Samuels S, Abramson SB (2013) Prognostic biomarkers in osteoarthritis. Curr Opin Rheumatol 25:136–144
Kim BJ, Yu YM, Kim EN, Chung YE, Koh JM, Kim GS (2007) Relationship between serum hsCRP concentration and biochemical bone turnover markers in healthy pre- and postmenopausal women. Clin Endocrinol (Oxf) 67(1):152–158
Hafez EA, Mansour HE, Hamza SH, Moftah SG, Younes TB, Ismail MA (2011) Bone mineral density changes in patients with recent-onset rheumatoid arthritis. Clin Med Insights Arthritis Musculoskelet Disord 4:87–94
Benhamou M, Gossec L, Dougados M (2010) Clinical relevance of C-reactive protein in ankylosing spondylitis and evaluation of the NSAIDs/coxibs’ treatment effect on C-reactive protein. Rheumatol 49(3):536–541
Handa R (2003) Approach seronegative arthritis. JIACM 4(3):190–192
Filipowicz R, Greene T, Wei G, Cheung AK, Raphael KL, Baird BC, Beddhu S (2013) Associations of serum skeletal alkaline phosphatase with elevated C-reactive protein and mortality. Clin J Am Soc Nephrol 8(1):26–32
El-Maouche D, Xu X, Cofrancesco J, Adrian S, Dobs AS, Brown TT (2011) Prevalence of low bone mineral density in a low-income inner-city population. J Bone Miner Res 26(2):388–396
Scorei R (2011) Boron compounds in the breast cancer cells. Chemoprevention and chemotherapy. In: Gunduz E, Gunduz M (eds) Breast cancer—current and alternative therapeutic modalities. InTech, Rijeka, pp 92–114
Scorei RI, Popa R (2013) Sugar-borate esters—potential chemical agents in prostate cancer chemoprevention. AntiCancer Agents Med Chem 13(6):901–909
Scorei R (2013) Regulation of therapeutic potential of boron-containing compounds. In: Kretsinger RH, Uversky VN, Permyakov EA (eds) Encyclopedia of metalloproteins, 1st edn. Springer, Berlin, p 100
Hu H, Penn S, Lebrillo C, Brown PH (1997) Isolation and characterization of soluble boron complexes in higher plants. Plant Physiol 113:649–55
Criste RD, Grossu DV, Scorei R et al. (2005) New investigations on the effect of the dietary boron on broilers and layers: boron and food quality. Arch Zoot 8:65–78. [Available at http://www.ibna.ro/arhiva/AZ%208/AZ%208_06%20RCriste.pdf] Accessed 26 April 2013
Taranu I, Marin DE, Manda G, Motiu M, Neagoe I, Tabuc C, Stancu M, Olteanu M (2011) Assessment of the potential of a boron-fructose additive in counteracting the toxic effect of Fusarium mycotoxins. Br J Nutr 106(3):398–407
Dessein PH, Stanwix AE, Joffe BJ (2002) Cardiovascular risk in rheumatoid arthritis versus osteoarthritis: acute phase response related decreased insulin sensitivity and high-density lipoprotein cholesterol as well as clustering of metabolic syndrome features in rheumatoid arthritis. Arthritis Res 4:R5
Ghivercea V, Grecu D, Lichiardopol C, Maria R (2004) Tratamentul osteoporozei cu fructoborat de calciu. Revista de Ortopedie si Traumatologie (Bucuresti) 14(1–2):75–82
Scorei R, Cimpoiasu VM, Iordachescu D (2005) In vitro evaluation of the antioxidant activity of calcium fructoborate. Biol Trace Elem Res 107:127–134
Park M, Li Q, Shcheynikov N, Zeng W, Muallem S (2004) NaBC1 is a ubiquitous electrogenic Na+-coupled borate transporter essential for cellular boron homeostasis and cell growth and proliferation. Mol Cell 16:331–341
Scorei R, Ciubar R, Ciofrangeanu CM, Mitran V, Cimpean A, Iordachescu D (2008) Comparative effects of boric acid and calcium fructoborate on breast cancer cells. Biol Trace Elem Res 122:197–205
Bienert GP, Chaumont F (2013) Aquaporins and boron. In: Kretsinger RH, Uversky VN, Permyakov EA (eds) Encyclopedia of metalloproteins, 1st edn. Springer, Berlin, p 100
Scorei R (2012) Is boron a prebiotic element? A mini-review of the essentiality of boron for the appearance of life on Earth. Orig Life Evol Biosph 42(1):3–17
Bassil E, Hu H, Brown PH (2004) Use of phenylboronic acids to investigate boron function in plants. Possible role of boron in transvacuolar cytoplasmic strands and cell-to-wall adhesion. Plant Physiol 136(2):3383–5
Hunt CD (2002) Boron-binding biomolecules: a key to understanding the beneficial physiologic effects of dietary boron from prokaryotes to humans. In: Goldbach HE, Rerkasem B, Wimmer MA, Brown PH, Thellier M, Bell RW (eds) Boron in plant and animal nutrition. Kluwer, New York, pp 21–36
Meacham S, Karakas S, Wallace A, Altun F (2010) Boron in human health: evidence for dietary recommendations and public policies. Open Miner Process J 3:36–53
Acknowledgments
This study was supported by Bioboron Research Institute from Craiova (Romania).
Conflict of Interest
The authors declare that they have no competing interests. The authors alone are responsible for the content and writing of this paper.
Author information
Authors and Affiliations
Corresponding author
Additional information
All the authors contributed equally to this work.
Rights and permissions
About this article
Cite this article
Scorei, I.D., Scorei, R.I. Calcium Fructoborate Helps Control Inflammation Associated with Diminished Bone Health. Biol Trace Elem Res 155, 315–321 (2013). https://doi.org/10.1007/s12011-013-9800-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12011-013-9800-y